ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 118 filers reported holding ACCELERON PHARMA INC in Q1 2015. The put-call ratio across all filers is 0.99 and the average weighting 1.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $1,518,000 | -21.8% | 41,944 | -26.6% | 0.36% | +1.7% |
| Q2 2016 | $1,942,000 | -20.0% | 57,148 | -37.8% | 0.36% | +2.0% |
| Q1 2016 | $2,426,000 | -55.1% | 91,943 | -17.0% | 0.35% | -39.9% |
| Q4 2015 | $5,403,000 | +138.5% | 110,801 | +21.8% | 0.58% | +167.0% |
| Q3 2015 | $2,265,000 | -39.7% | 90,957 | -23.4% | 0.22% | -40.6% |
| Q2 2015 | $3,757,000 | +342.0% | 118,728 | +431.5% | 0.37% | +342.2% |
| Q1 2015 | $850,000 | +140.8% | 22,340 | +114.9% | 0.08% | +196.4% |
| Q2 2014 | $353,000 | -35.5% | 10,397 | -34.4% | 0.03% | -22.2% |
| Q1 2014 | $547,000 | +69.3% | 15,852 | +94.5% | 0.04% | +140.0% |
| Q4 2013 | $323,000 | – | 8,149 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 42,030 | $3,777,000 | 6.01% |
| Artal Group S.A. | 1,500,000 | $134,805,000 | 5.70% |
| GREAT POINT PARTNERS LLC | 535,627 | $48,137,000 | 5.03% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 211,038 | $18,966,000 | 3.47% |
| Cormorant Asset Management, LP | 825,000 | $74,143,000 | 3.44% |
| Graticule Asia Macro Advisors LLC | 48,700 | $4,377,000 | 3.20% |
| Avoro Capital Advisors LLC | 860,000 | $77,288,000 | 2.61% |
| QVT Financial LP | 120,264 | $10,808,000 | 2.52% |
| Ikarian Capital, LLC | 316,900 | $28,480,000 | 2.14% |
| Avidity Partners Management LP | 166,000 | $14,918,000 | 2.06% |